Comparative Effectiveness In U.S. Will Not Be Like NICE, OMB’s Orszag says

White House Office of Management and Budget Director Peter Orszag made it clear that the administration is not looking to build a government entity charged with making cost-effectiveness decisions when reviewing the clinical effectiveness of medical treatments